Outlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Nancy Dreyer, IQVIA
Advertisement
Articles by Nancy Dreyer, IQVIA
Advertisement
Latest Updated Articles
The True Reliability of Real-World DataPublished: August 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals
2
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
3
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
4
HDA 2025 Traceability Seminar: DSCSA Compliance Ushers in a More Secure and Transparent Pharma Supply Chain
5
